Wendy Mayer of Pfizer recaps some of the key points from her session at InnoLead’s 2017 Teach-In, “Driving Transformative Change at Pfizer.” Mayer, VP of Strategy at Pfizer, explains the need to separate incremental innovation work from transformational efforts; why its important to have “a framework and a process to guide you”; and how you demonstrate value and get senior leadership buy-in.
“As humans, we have limitations in being able to integrate and synthesize and look at data,” says venture capitalist John Orloff, formerly Global Head of R&D at Alexion Pharmaceuticals. “I think AI and machine learning technology will allow us to make better decisions and choices, and give us new insights...
